2-Hydroxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95%, 250mg

5,7-dimethyl-6-(4-methylbenzyl)pyrazolo[1,5-a]pyrimidine-3-carboxylic acid, 100mg

3-Bromo-4-(trifluoromethyl)benzaldehyde, 95.0%, 250mg

(3-Formyl-5-(trifluoromethoxy)phenyl)boronic acid, 96%, 1g

(1S)-1-{4-Amino-5-[(1S)-1-hydroxyethyl]-4H-1,2,4-triazol-3-yl}ethan-1-ol, 90.0%, 100mg

2-Methoxyethane-1-sulfonyl fluoride, 97%, 500mg

4-Amino-2,6-difluorophenylacetylene, 100mg

4-Methoxy-D-phenylalanine, 95.0%, 1g

7-chloro-1-(4-chlorophenyl)-1-oxoheptane, 97.0%, 5g

Ethyl 1,2-dimethyl-1H-pyrrole-3-carboxylate, 97%, 10g

p-Tolylmethanol, 95.0%, 500g

(S)-1-N-Boc-3-Hydroxypiperidine, 98.0%, 500g

GC capillary column ROTI®Cap-5 HT, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)